Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-040193
Filing Date
2025-04-28
Accepted
2025-04-28 16:07:43
Documents
21
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm252486-4_def14a.htm   iXBRL DEF 14A 634146
4 GRAPHIC lg_cognition-4c.jpg GRAPHIC 14880
5 GRAPHIC ic_mail-bw.jpg GRAPHIC 4093
6 GRAPHIC ic_internet-bw.jpg GRAPHIC 4907
7 GRAPHIC ic_phone-bw.jpg GRAPHIC 4579
8 GRAPHIC ic_meeting-bw.jpg GRAPHIC 3962
9 GRAPHIC ic_tick-bw.jpg GRAPHIC 1820
10 GRAPHIC px_25cognitproxy01pg01-bw.jpg GRAPHIC 224605
11 GRAPHIC px_25cognitproxy01pg02-bw.jpg GRAPHIC 152624
  Complete submission text file 0001104659-25-040193.txt   1956661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20241231.xsd EX-101.SCH 9048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20241231_lab.xml EX-101.LAB 33989
23 EXTRACTED XBRL INSTANCE DOCUMENT tm252486-4_def14a_htm.xml XML 4609
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40886 | Film No.: 25880339
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)